Indicators

Markets:

News

Latest News about RGNX

Recent news which mentions RGNX

< Previous 1 2 3 4 5 Next >

Expert Ratings for Regenxbio

May 05, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

3 Small-Cap Medical Stocks With Big Momentum

April 27, 2022

7 Top-Rated Biotech Stocks to Buy for Q2

April 21, 2022

Regenxbio's Return On Capital Employed Overview

March 07, 2022

Expert Ratings For Regenxbio

March 02, 2022

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi

March 02, 2022

Regenxbio: Q4 Earnings Insights

March 01, 2022

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution

March 01, 2022

Earnings Scheduled For March 1, 2022

March 01, 2022

Earnings Preview: Regenxbio

February 28, 2022

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

February 27, 2022

RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial

February 09, 2022

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In

February 09, 2022

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Expert Ratings For Regenxbio

January 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021

December 15, 2021

RegenXbio's Duchenne Gene Therapy Secures FDA Orphan Drug Tag

November 22, 2021

70 Biggest Movers From Yesterday

November 16, 2021

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares

November 12, 2021

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More

November 08, 2021

Barron's Latest Picks And Pans: Alleghany, Blade Air Mobility, Gene Therapy Picks And More

November 06, 2021

REGENXBIO inc (RGNX) Q3 2021 Earnings Call Transcript

November 03, 2021

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US

November 02, 2021

Earnings Scheduled For November 2, 2021

November 02, 2021

Earnings Outlook For Regenxbio

November 01, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

3 High-Yield Dividend Stocks I'm Not Selling Anytime Soon

October 18, 2021

Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial

October 11, 2021

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage

October 10, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.